GAP Analysis

GAP analysis is a systematic assessment of the differences or “gaps” between the current state of a clinical trial or regulatory process and the desired or required state for successful registration and market authorization. This analysis is critical for identifying and addressing deficiencies, ensuring compliance with regulatory standards, and expediting the approval and market launch of drugs and medical devices.